Mediclinic Precise Launches Non-Invasive Prenatal Testing
Mediclinic is now offering safe, non-invasive prenatal testing (NIPT) for expectant parents as part of their DNA-based diagnostic and clinical interpretation services. This is a recent...
Neutral
or
Mediclinic ADR News & Analysis
-
-
Why Top SA Tech Careers Are Being Built In Healthcare
By 2022, the value of the South African healthcare market was predicted to reach over R681 billion, and this is expected to rise to over R865 billion by 2027. As both the public and...
-
Mediclinic Southern Africa Takes A Bet On Precision Medicine With Acquisition Of Artisan Biomed
Mediclinic (LON:MDCM) Southern Africa is taking a bet on precision medicine with the acquisition of an 80% shareholding in Artisan Biomed, a subsidiary of the Centre for Proteomic &...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
